Unilever and Arzeda, the industry-leading Protein Design Company™, have entered a strategic partnership to apply the latest advances in digital biology to discovering and design
Codexis and existing Series A investor, Casdin Capital, have co-invested in Arzeda as part of the SynBio Innovation Accelerator. In addition to the capital investment, Codexis and
Arzeda, the Protein Design Company™, today announced that biotechnology veteran Doug Cameron, PhD has joined the company’s board of directors. Dr. Cameron brings three decades
Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary nature of the tw
BP and Arzeda, the Protein Design Company™, are pleased to announce they have entered a second extended collaboration agreement for developing a bio-process for production of a r
Arzeda, the Protein Design Company™, has been featured in GeekWire: Inside Arzeda’s synthetic biology lab, where industrial ingredients are brewed like beer.
Arzeda, the Protein Design Company™, has been featured in the April 6th issue of The Economist’s Technology Quarterly on synthetic biology.
Prev post
Next post
Arzeda, the Protein Design Company™, has been recognized for the third time as among the top companies in the advanced bioeconomy in the annual rankings by Biofuels Digest, the w
Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad applications.
This collaboration will lev
